Patients now living a median 6.8 years after stage IV ALK+ lung cancer diagnosis

(University of Colorado Anschutz Medical Campus) Stage IV ALK+ lung cancer patients treated at UCHealth University of Colorado Hospital between 2009 and 2017 had median overall survival of 6.8 years.